• Home
  • News
  • Portfolio News
  • Aras Announces Audi, BMW, L3, Microsoft, and Schaeffler to Headline ACE 2018 Global Conference on Digital Transformation

Aras Announces Audi, BMW, L3, Microsoft, and Schaeffler to Headline ACE 2018 Global Conference on Digital Transformation

27Feb

Aras Announces Audi, BMW, L3, Microsoft, and Schaeffler to Headline ACE 2018 Global Conference on Digital Transformation

Portfolio News

Aras, the leader in open, enterprise product lifecycle management (PLM) software, today announced that speakers from Audi, BMW, L3, Microsoft, and Schaeffler will headline ACE 2018, the global conference for the Aras community, scheduled for March 20-22 in Indianapolis, IN. In addition, David J. Kappos, former director of the U.S. Patent Office, will discuss innovation. Read more >>

Share this post

Related Posts

08Mar

Aircuity CEO talks about the launch of “adaptive airflow” solution for cleanrooms

Dynamic cleanroom control is a game-changer for many highly regulated industries. Providing a cost saving, whilst simultaneously decarbonising the facility’s... read more
23Nov

Thurston High musician close to goal for getting electronic glasses

Reilly Gault, a Thurston High School student and musician who is legally blind, is raising money for computerized glasses. Read... read more
19Jan

Forward Thinking Blog A Hopeful CES Trend: Tech for the Visually and Hearing-Impaired

eSight has another approach, using electronic glasses that can actually enable some legally blind people to see. Read more >> read more
31Mar

XCOR Partners With Syncroness, Inc. for Rapid Product Development

XCOR Aerospace, a pioneer in the rapid development of long-life, reusable rocket engines, has recently chosen Syncroness, Inc. of Westminster,... read more
07Feb

Carbonite to Present at the JMP Securities Technology Conference on Monday February 27th, 2017

Carbonite, Inc., a leading provider of data protection solutions for small and midsize businesses, announced its upcoming participation at the... read more
14Oct

Takeda bets up to $900M on Immusoft’s cell therapies for neurometabolic disorders

              Immusoft has inked its first Big Pharma collaboration in a deal with biotech's best friend Takeda worth up to $900... read more
01Mar

Xylyx Bio launches new website to showcase growing portfolio of regenerative biotechnologies

Xylyx Bio, a New York-based regenerative medicine company leading the development of advanced biomaterials and biosystems, is proud to announce... read more
21Feb

Space Startups Are Booming in the Mojave Desert

Inside a series of nondescript buildings in the ­driest desert in North America, an entrepreneurial enclave is chasing the next... read more
16Mar

Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO”

Myomo, a privately held medical device company spun out of MIT, has launched an unusually structured public offering of stock... read more
23Mar

Myomo inks Italian sales deal

Myomo recently announced that it has signed a sales and service agreement with Progettiamo Autonomia Robotics (PAR) to market the... read more